Satellos Bioscience Inc. (MSCL.TO)

CAD 0.89

(-4.3%)

Revenue Summary of Satellos Bioscience Inc.

  • Satellos Bioscience Inc.'s latest annual revenue in 2023 was - CAD , down 0.0% from previous year.
  • Satellos Bioscience Inc.'s latest quarterly revenue in 2024 Q1 was - CAD , down 0.0% from previous quarter.
  • Satellos Bioscience Inc. reported a annual revenue of - CAD in annual revenue 2022, down 0.0% from previous year.
  • Satellos Bioscience Inc. reported a annual revenue of - CAD in annual revenue 2021, down 0.0% from previous year.
  • Satellos Bioscience Inc. reported a quarterly revenue of - CAD for 2024 Q2, down 0.0% from previous quarter.
  • Satellos Bioscience Inc. reported a quarterly revenue of - CAD for 2023 Q3, down 0.0% from previous quarter.

Annual Revenue Chart of Satellos Bioscience Inc. (2023 - 2019)

Historical Annual Revenue of Satellos Bioscience Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 - CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%
2020 - CAD -100.0%
2019 25 Thousand CAD 0.0%

Peer Revenue Comparison of Satellos Bioscience Inc.

Name Revenue Revenue Difference
Appili Therapeutics Inc. 827.4 Thousand CAD 100.0%
Eupraxia Pharmaceuticals Inc. - CAD NaN%
Helix BioPharma Corp. - CAD NaN%
Microbix Biosystems Inc. 16.51 Million CAD 100.0%
Medicenna Therapeutics Corp. - CAD NaN%
Oncolytics Biotech Inc. - CAD NaN%
Sernova Corp. - CAD NaN%